Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$70.9M
+55.8% from 2023
Prescriptions
100K
$710.05 per claim
Patients
30K
17,945 prescribers
Total spending, 2024
$70.9M
$2,360.22 per patient
Medicare prescription drug plans paid $70.9M for Nexletol in 2024, for 99,852 prescriptions and refills to 30,036 patients (up 55.8% from 2023). The average cost per claim was $710.05.
New York had the highest Medicare cost for Nexletol in 2024: $8.2M for 12,127 claims, followed by California ($7.2M).
Steven Kong, physician assistant in Brooklyn, NY, had the highest Medicare cost for Nexletol in 2024: 1,306 claims costing $604K.
Nexletol is made by Esperion Therapeutics, Inc. (ESPR), listed in the Medicare spending data as Esperion Therap.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Steven Kong Brooklyn, NY | Physician Assistant | 1,306 | 175 | $604K |
| Johannes D Veldhuis Meridian, ID | Endocrinology | 224 | 81 | $197K |
| Henry K Siu New York, NY |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 6,978 | 43,279 | 11,234 | $29.0M |
| 2023 | 11,842 | 63,183 | 18,612 | $45.5M |
| 2024 | 17,945 | 99,852 | 30,036 | $70.9M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Interventional Cardiology |
| 208 |
| 51 |
| $149K |
| Sandeep A Patel Thibodaux, LA | Interventional Cardiology | 204 | 52 | $115K |
| Ziad A Abbud Neptune, NJ | Interventional Cardiology | 118 | 31 | $95K |
| Kerry K Nie Dayton, OH | Physician Assistant | 222 | 64 | $91K |
| Paul B Duell Portland, OR | Endocrinology | 100 | 34 | $89K |
| Hercules Panayiotou Mobile, AL | Cardiology | 125 | 30 | $87K |
| Don W Lee Glendale, CA | Interventional Cardiology | 174 | 25 | $81K |
| Janice McAlister Atlanta, GA | Nurse Practitioner | 146 | 26 | $78K |
| Peter Baciewicz Seattle, WA | Cardiology | 78 | 27 | $76K |
| James A Trippi Indianapolis, IN | Cardiology | 103 | 25 | $76K |
| Sherwin D'Souza Pocatello, ID | Internal Medicine | 76 | 32 | $75K |
| Tu N Truong San Diego, CA | Internal Medicine | 111 | 27 | $70K |
| Douglas W Triffon La Jolla, CA | Cardiology | 74 | 21 | $70K |
| James M Brennan Durham, NC | Cardiology | 116 | 26 | $69K |
| Stephanie Saucier Hartford, CT | Internal Medicine | 95 | 26 | $69K |
| Edmond Melikterminas Burbank, CA | Internal Medicine | 155 | 23 | $67K |
| Larry M Neuman New York, NY | Internal Medicine | 138 | 35 | $66K |
| Gevork J Maissian Glendale, CA | Internal Medicine | 160 | 17 | $66K |
| Geena D Eglin Wilmington, NC | Pharmacist | 78 | 19 | $66K |
| Hrach Khudatyan Glendale, CA | Family Practice | 135 | 17 | $64K |
| Lan Luo Ocala, FL | Cardiology | 103 | 29 | $63K |
| Yili Huang Elmhurst, NY | Cardiology | 120 | 22 | $62K |
| James F Orlando Neptune, NJ | Cardiology | 65 | 18 | $60K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Esperion Therap ESPR | 99,877 | $70.9M |